MPA
CELG

Marvin & Palmer Associates’s Celgene Corp CELG Stock Holding History

Marvin & Palmer Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,260
Closed -$3.54M – 46
2017
Q3 		$3.54M Buy
+24,260
New +$3.3M 4.35% 7
2016
Q1 		– Sell
-9,875
Closed -$1.18M – 59
2015
Q4 		$1.18M Sell
9,875
-300
-3% -$34.7K 1.21% 36
2015
Q3 		$1.1M Sell
10,175
-1,375
-12% -$171K 1.32% 36
2015
Q2 		$1.34M Sell
11,550
-100
-0.9% -$11.4K 1.27% 36
2015
Q1 		$1.34M Buy
11,650
+1,572
+16% +$188K 1.16% 41
2014
Q4 		$1.13M Buy
+10,078
New +$1.06M 1.15% 36
2014
Q1 		– Sell
-16,500
Closed -$1.39M – 80
2013
Q4 		$1.39M Buy
16,500
+100
+0.6% +$7.91K 0.84% 51
2013
Q3 		$1.26M Sell
16,400
-27,800
-63% -$1.95M 0.83% 50
2013
Q2 		$2.58M Buy
+44,200
New +$2.66M 1.4% 26

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Marvin & Palmer Associates's CELG Position: Q4 2017 in Review

Marvin & Palmer Associates sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 24,260 shares — an estimated $3.54M sold.

Marvin & Palmer Associates first reported a position in CELG in Q2 2013 and held it in 9 quarters. The position peaked at $3.54M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Marvin & Palmer Associates reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Marvin & Palmer Associates sold 24,260 Celgene Corp shares in Q4 2017, an estimated $3.54M.
  • Marvin & Palmer Associates first reported a position in Celgene Corp in Q2 2013 and held it in 9 quarters.
  • Marvin & Palmer Associates's Celgene Corp position peaked at $3.54M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Marvin & Palmer Associates's 13F filing for Q4 2017, filed 13 Feb 2018.